A. Di Stefano (Veruno, Italy), P. Kirkham (Wolverhampton , United Kingdom), I. Vachier (Montpellier, France), L. Stanciu (Cluj-Napoca, Romania)
Real life distribution of the COPD patients in GOLD groups A to D in German population: DACCORD registry
H. Worth, R. Buhl, C. P. Criée, P. Kardos, C. Vogelmeier (Fuerth, Mainz, Bovenden, Frankfurt am Main, Marburg, Germany)
|  |
Frequency of COPD exacerbations in the real-life out-patient DACCORD cohort
C. Vogelmeier, R. Buhl, C. P. Criée, P. Kardos, H. Worth (Marburg, Mainz, Bovenden, Frankfurt am Main, Fuerth, Germany)
| |
Effects of inhaled steroid therapy on exhaled breath condensate and blood biomarkers in newly diagnosed smoker asthmatics
B. Gemicioglu, B. Duman, N. Akdeniz, S. Gazioglu, G. Deniz, N. Yildirim (Istanbul, Turkey)
|  |
Effects of sex hormones on bronchial reactivity during the menstrual cycle
F. Polverino, M. Matteis, G. Spaziano, F. Roviezzo, C. Santoriello, M. Laucho Contreras, N. Sullo, M. R. Bucci, F. Rossi, C. A. Owen, M. Polverino, B. D'Agostino (Boston, United States Of America; Naples, Scafati, Parma, Italy)
| |
Factors associated with lower physical activity in patients with COPD
A. Kocabas, E. Ozyilmaz, Y. Soydas, G. Tezcagirir, M. Ocak (Adana, Turkey)
| |
Abediterol has higher bronchodilatory potency and reduced cardiac effects versus other long-acting beta2-agonists in dogs
A. Gavaldà, J. L. Montero, M. Aparici, C. Puig, C. Doe, M. Miralpeix (Barcelona, Spain)
| |
Effect of cromolyn inhaler on resistant neutrophilic cough variant of asthma, A phase two clinical trial
M. Mirsadraei, Z. Sabbagh Sajadieh, S. Sabbagh Sajadieh (Mashhad, Islamic Republic Of Iran)
| |
The performance of a new vibrating mesh prototype nebulizer for inhaled biodrugs
D. Marchand, C. Maria, M. Pinel, T. Nicolini, L. Vecellio (Tours, Saint Etienne, France)
| |
Comparison of an innovative multi-dose inhaler with the attributes of an 'ideal' inhaler: A multicentre randomised controlled trial (RCT)
S. Jones, R. Clarke, S. Eason, P. Swanbury, A. Scrimgeour, N. Ellis (Holzkirchen, Germany; Cambridge, Chippenham, United Kingdom)
| |
Pharmacokinetic (PK) analysis of fluticasone furoate (FF), umeclidinium (UMEC) and vilanterol (VI) following triple therapy at two UMEC doses in healthy subjects
A. Henderson, A. Allen, A. Gupta, J. Renaux, N. Brealey (Stevenage, Uxbridge, United Kingdom; Bangalore, India)
| |
Comparison of the particle size distribution of fluticasone propionate/formoterol and beclometasone/formoterol MDI using laser diffraction
P. Haidl, G. Scheuch, C. Kietzig, D. Kappeler, R. Cloes (Schmallenberg-Grafschaft, Gemuenden/Wohra, Gauting, Limburg/Lahn, Germany)
| |
In vitro analysis of two formulations of fluticasone/ salmeterol pMDI for delivered dose uniformity and aerodynamic particle size distribution
G. Malhotra, K. Rote, A. Sawant, J. Gogtay (Mumbai, India)
| |
Comparison of inspiratory flow rates using an innovative dry powder inhaler (DPI) in patients with mild–severe asthma and severe COPD
S. Jones, I. Gath, T. Weuthen (Holzkirchen, Rudolstadt, Germany)
| |
A novel biophysical simulation model predicts consistent lung delivery of QVA149, glycopyrronium and indacaterol via the Breezhaler® device
A. Kuttler, T. Dimke (Basel, Switzerland)
| |
Targeted lung denervation in the healthy sheep model - A potential treatment for COPD
M. Mayse, P. Johnson, J. Streeter, M. Deem, J. Hummel (Minneapolis, Menlo Park, Chapel Hill, United States Of America)
| |
Allergen exposed primary human bronchial epithelial cells have inhibited transport of salbutamol sulphate only when functional organic cation tranporters are present
Q. Zeng, Q. Ge, M. Haghi, J. Rimmer, R. Harvey, P. Young, D. Traini, J. Shi, J. Black, J. Burgess, B. Oliver (Sydney, Australia; Guangzhou, China)
| |
The effect of Vitamin D deficiency on lung function in current smoker COPD patients
A. Kocabas, E. Ozyilmaz, M. Ocak, G. Seydaoglu (Adana, Turkey)
| |
HSP60 activity on 16HBE cells after oxidative and pro-inflammatory stimuli
D. Vallese, A. Pitruzzella, I. Gnemmi, F. Bucchieri, F. Cappello, B. Balbi, A. J. L. Macario, E. Conway de Macario, A. Di Stefano (Veruno (NO), Palermo, Italy; Baltimore, United States Of America)
| |
Expression of Th1, Th2 and Th17 cytokines in CD4+ T cells in peripheral blood of asthma patients
L. Cervis, M. Jung, T. Schiffer, S. Korn, R. Buhl (Mainz, Germany)
| |